Severe Hemophilia B
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Long-Term Safety and Efficacy of rFIXFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia B (NCT01425723) | Bioverativ Therapeutics Inc. | 2011-12-08 |
| Study of Recombinant Factor IX Fc Fusion Protein (rFIXFc) in Participants With Hemophilia B (NCT01027364) | Bioverativ Therapeutics Inc. | 2009-12-01 |
Track Severe Hemophilia B automatically
Every clearance here is in the API, with alerts when new ones post.